Solventum (SOLV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Solventum (SOLV) is Neutral.

The composite score behind that read is -0.06, weighing +0.24 of bullish evidence against -0.30 bearish.

Solventum last closed at $88.03, +0.20% on the session.

Against the IVW growth benchmark the position is -0.72% over the forecast window.

The read is built from 13 underlying insights — 6 bullish and 7 bearish.

Agreement across those insights is 54%.

3 graded predictions for SOLV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Solventum in the 81st percentile on valuation and the 87th percentile on return on equity, where 100 is best.

Solventum is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $14.95B.

StockMap tracks Solventum as the 17th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Solventum ranks 23rd of 133 in the group, against a group median of -0.21.